Evidence map›Paper›PMID 33580568›Full record

Observational studyClinical genetics2021

Health-related quality of life in adults with osteogenesis imperfecta.

Chaya N Murali, Brady Slater, Salma Musaad, David Cuthbertson, Dianne Nguyen, Alicia Turner, Mahshid Azamian, Laura Tosi, Frank Rauch, V Reid Sutton and 3 more

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Clinical genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Osteogenesis imperfecta and the family: A qualitative analysis of the experiences of family and caregivers.Families, systems & health : the journal of collaborative family healthcare · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Chaya N MuraliDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-9781-3387
Brady SlaterDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Salma MusaadDepartment of Pediatrics-Nutrition, Baylor College of Medicine, Houston, Texas, USA.
David CuthbertsonCollege of Medicine, University of South Florida, Tampa, Florida, USA.
Dianne NguyenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Alicia TurnerDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Mahshid AzamianDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Laura TosiBone Health Program, Children's National Health System, Washington D.C., Washington, USA.
Frank RauchShriner's Hospital of Children, McGill University, Montreal, Quebec, Canada.
V Reid SuttonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Brendan LeeDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Members of the BBD Consortium
Sandesh C S NagamaniDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-6818-7367
Baylor College of Medicine · USAgricultural Research Service · USChildren's National · USMontreal Children's Hospital · CAUniversity of South Florida · US

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI Michal Kouril · 2019 to 2026
$51.2M
Project 3: 3D ImagingU54AR068069 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI Brendan Lee · 2014 to 2026
$19.3M
Preclinical and Clincial OutcomesP50HD103555 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI Sandesh Chakravarthy Sreenath Nagamani, David Loren Nelson · 2020 to 2026
$9.9M
NCATS NIH HHS U2C TR002818NIAMS NIH HHS U54 AR068069NICHD NIH HHS P50 HD103555
6 · The paper itself

Abstract

Patient-reported outcome measures (PROMs) are increasingly utilized as endpoints in clinical trials. The Short Form Health Survey-12 (SF-12v2) is a generic PROM for adults. We sought to evaluate the validity of SF-12v2 in adults with osteogenesis imperfecta (OI). Physical and mental health-related quality of life (HRQoL) were assessed in a large cohort of adults in a multicenter, observational, natural history study. Physical HRQoL scores were correlated with the Gillette Functional Assessment Questionnaire (GFAQ). We calculated sample sizes required in clinical trials with crossover and parallel-group designs to detect clinically meaningful changes in physical HRQoL. Three hundred and two adults with OI types I, III, and IV were enrolled. Physical HRQoL scores in the study population were lower than population norms. Physical HRQoL scores moderately correlated with GFAQ for OI types I and IV. We found no correlations between mental and physical HRQoL. From a clinical trial readiness perspective, we show that SF-12v2 reliably measures physical function in adults with OI and can be utilized in crossover trials to detect meaningful physical HRQoL changes with small sample sizes. This study shows that SF-12v2 can be used to measure changes in physical HRQoL in response to interventions in OI.

Indexed as

AdultCohort StudiesCross-Over StudiesFemaleHumansMaleMiddle AgedOsteogenesis ImperfectaQuality of LifeSurveys and QuestionnairesYoung Adultnatural historyosteogenesis imperfectaquality of lifesample size

Identifiers

PMID33580568
PMCPMC8096695
OpenAlexW3128119710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.